Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
14.59 EUR | 0.00% | +2.82% | +23.14% |
Mar. 05 | Transcript : COFACE SA - Analyst/Investor Day | |
Mar. 04 | Coface: raises its financial targets for 2024-2027 | CF |
Sales 2023 | 1.87B 2.01B | Sales 2024 * | 1.92B 2.07B | Capitalization | 2.18B 2.35B |
---|---|---|---|---|---|
Net income 2023 | 241M 260M | Net income 2024 * | 234M 252M | EV / Sales 2023 | 0.94 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 1.14 x |
P/E ratio 2023 |
7.35
x | P/E ratio 2024 * |
9.3
x | Employees | 4,100 |
Yield 2023 * |
8.77% | Yield 2024 * |
8.68% | Free-Float | 98.33% |
Latest transcript on Coface SA
1 day | -0.07% | ||
1 week | +2.82% | ||
Current month | +9.95% | ||
1 month | +6.35% | ||
3 months | +22.42% | ||
6 months | +19.12% | ||
Current year | +23.14% |
Managers | Title | Age | Since |
---|---|---|---|
Xavier Durand
CEO | Chief Executive Officer | 59 | 16-01-14 |
Phalla Gervais
DFI | Director of Finance/CFO | 56 | 21-08-31 |
Matthieu Garnier
CTO | Chief Tech/Sci/R&D Officer | - | 22-09-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 61 | 21-02-09 | |
Chairman | 64 | 21-02-09 | |
Sharon MacBeath
BRD | Director/Board Member | 55 | 14-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 29 M€ | +8.37% | - | |
0.01% | 735 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 14.59 | 0.00% | 40 801 |
24-03-27 | 14.59 | +0.62% | 310,113 |
24-03-26 | 14.5 | +0.07% | 275,620 |
24-03-25 | 14.49 | +2.62% | 320,451 |
24-03-22 | 14.12 | -0.42% | 223,193 |
Real-time Euronext Paris, March 28, 2024 at 05:32 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+23.14% | 2.36B | |
+33.89% | 62.12B | |
+15.63% | 53.35B | |
+20.13% | 52.43B | |
+21.33% | 44.68B | |
+23.17% | 34.09B | |
+8.16% | 28.95B | |
+44.13% | 28.53B | |
+20.09% | 24.79B | |
+24.67% | 22.62B |